Automated Cath Labs to Enhance Cardiovascular Care in India

GE Healthcare’s introduction of its first made-in-India artificial intelligence-enabled catheter lab diagnostic imaging platform will ultimately lead to better patient care in the country, claims GlobalData. 

The Optima IGS 320 launched earlier ths year will guide non-invasive cardiovascular procedures with better precision and versatility. GlobalData forecasts the Indian cardiovascular devices market to grow 5% annually through 2030. Research and development of advanced technologies are expected to further drive the market.
 
“Cardiovascular disorders (CVD) are becoming more prevalent in India, highlighting the need for affordable technology to match the rising demand for less invasive procedures,” said Shachee Singh, a medical devices analyst at GlobalData. “Products such as the Optima IGS 320 will support personalized treatment regimens for patients, with greater accuracy through automation of intricate cardiac and electrophysiology operations and intelligent imaging.”
 
GE Healthcare touts the Optima IGS 320 as a cost-effective visualization and imaging system with built-in neural-network-based AutoRight technology that can optimize dose settings in real time. Features such as the PCI ASSIST enhance image quality during risky procedures and make it an ideal solution for complex cardiac treatment interventions.
 
“With a shift in disease patterns and a rise in CVD incidence among the younger population of the country, quality cardiac care requires innovative healthcare solutions. Automated cath labs will reduce the workload of cardiologists and allow them to focus on providing better patient care,” Singh said.